About this trial
The investigators describe a protocol for a randomized controlled trial to find out the effect and safety of electroacupuncture on losing weight in obese patients with prediabetes.
Eligibility criteria
Qualifiers
Male or female participants aged 18-65;
Participant whose BMI is ≥24.0 kg/m2;
Participants whose HbA1c measurement of 5.7-6.4% both inclusive, or fasting plasma glucose measurement ≥ 6.1 mmol/liter and <7.0 mmol/liter, or 2-hour plasma glucose measurement post-challenge (oral glucose tolerance test) ≥7.8 mmol/liter and <11.1 mmol/liter;
Participants with stable weight within 3 months before the start of the trial, fluctuated within 4 kg;
Disqualifiers
Patients with secondary obesity caused by drugs or neuro-endocrine-metabolic disorders (such as hypothalamic disease and hypopituitarism);
Patients who have been diagnosed with type I or type II diabetes;
Patients who are taking medication which cause clinically significant weight gain or loss;
Patients whose Hamilton 17-item Depression Scale (HAMD-17) score >18 or have a history of other severe psychiatric disorders;
Trial design
Treatments tested in this trial
- Electroacupuncture
- Sham acupuncture
- Health education